Abstract
Introduction: Type 1 diabetes mellitus (DM1) is one of the most frequent endocrine pathologies in pediatric population. Capillary blood glucose testing, the most recommended self-monitoring method, is associated with discomforts that could decrease adherence. This led to creation of new technologies that respond to patients’ needs. Objective: To generate recommendations based on experts consensus about the use of the ϔlash glucose monitor (FGM) in patients under 18 years of age with DM1 diagnosis. Materials and methods: A modiϔied Delphi-type consen-sus was carried out in which 8 specialists in pediatric endo-crinology and a developer group participated. Based on the analysis of the results, the recommendations were presented. Results: Recommendations about indications, frequency and mode of use, safety proϔile and impact of its use on quality of life were obtained.
Conclusions: The FGM has a precision comparable with capillary glucose. It is considered a safe device, with the ability to impact positively the quality of life of the patients and their caregivers.
Conclusions: The FGM has a precision comparable with capillary glucose. It is considered a safe device, with the ability to impact positively the quality of life of the patients and their caregivers.
| Translated title of the contribution | Consensus on the use of the fi rst generation fl ash glucose monitor in patients under 18 years of age diagnosed with type 1 diabetes mellitus |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 258-265 |
| Number of pages | 8 |
| Journal | Revista Colombiana de Endocrinoloǵıa, Diabetes & Metabolismo |
| Volume | 7 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Type 1 Diabetes Mellitus
- Child
- Adolescent
- Blood Glucose Self-monitoring
- Flash Glucose Monitoring System
Fingerprint
Dive into the research topics of 'Consensus on the use of the fi rst generation fl ash glucose monitor in patients under 18 years of age diagnosed with type 1 diabetes mellitus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver